ScholarIQanswers from OpenAlex & ORCID
H. Joachim Deeg
ResearcherPublications, citations & collaboration network
H. Joachim Deeg is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does H. Joachim Deeg have?
ScholarIQindexed works
H. Joachim Deeg has 990 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does H. Joachim Deeg have?
ScholarIQcitation count
H. Joachim Deeg has 59,666 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of H. Joachim Deeg?
ScholarIQh-index
H. Joachim Deeg has an h-index of 118 in OpenAlex.
What is the i10-index of H. Joachim Deeg?
ScholarIQi10-index
H. Joachim Deeg has an i10-index of 536 in OpenAlex.
What is the ORCID of H. Joachim Deeg?
ScholarIQorcid
The ORCID for H. Joachim Deeg is on the source record.
What is the OpenAlex record for H. Joachim Deeg?
ScholarIQopenalex
The OpenAlex for H. Joachim Deeg is on the source record.
What are the most-cited papers on H. Joachim Deeg?
ScholarIQmost cited works
Allogeneic hematopoietic stem cell transplantation for myelofibrosis
H. Joachim Deeg, Theodore A. Gooley, Mary E.D. Flowers, George E. Sale, John T. Slattery, Claudio Anasetti, Thomas R. Chauncey, K Doney, George E. Georges, Hans‐Peter Kiem, Paul J. Martin, Effie W. Petersdorf, Jerald P. Radich, Jean E. Sanders, Brenda M. Sandmaier, Edus H. Warren, Robert P. Witherspoon, Rainer Storb, Frederick R. Appelbaum
Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation
Rainer Storb, Boglarka Gyurkocza, Barry E. Storer, Mohamed L. Sorror, Karl G. Blume, Dietger Niederwieser, Thomas R. Chauncey, Michael A. Pulsipher, Finn Bo Petersen, Firoozeh Sahebi, Edward Agura, Parameswaran Hari, Benedetto Bruno, Peter A. McSweeney, Michael B. Maris, Richard T. Maziarz, Amelia Langston, Wolfgang Bethge, Lars L. Vindeløv, Georg‐Nikolaus Franke, Ginna G. Laport, Andrew M. Yeager, Kai Hübel, H. Joachim Deeg, George E. Georges, Mary E.D. Flowers, Paul J. Martin, Marco Mielcarek, Ann E. Woolfrey, David G. Maloney, Brenda M. Sandmaier
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
David P. Steensma, Martin Wermke, Virginia M. Klimek, Peter L. Greenberg, Patricia Font, Rami S. Komrokji, Jay Yang, Andrew M. Brunner, Hetty E. Carraway, Lionel Adès, Aref Al‐Kali, Juan Manuel Alonso‐Domínguez, Ana Alfonso Piérola, Catherine C. Coombs, H. Joachim Deeg, Ian W. Flinn, James M. Foran, Guillermo Garcia‐Manero, Michael B. Maris, Malgorzata McMasters, Jean‐Baptiste Micol, Jaime Pérez de Oteyza, Felicitas Thol, Eunice S. Wang, Justin M. Watts, Justin Taylor, Richard M. Stone, Vikram Gourineni, Alyssa J. Marino, Huilan Yao, Benoit Destenaves, Xiaobin Yuan, Kun Yu, Sara Dar, Lernik Ohanjanian, Keisuke Kuida, Jianjun Xiao, Catherine Scholz, Antonio Gualberto, Uwe Platzbecker
Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential Thrombocythemia
Daniella Kerbauy, Theodore A. Gooley, George E. Sale, Mary E.D. Flowers, K Doney, George E. Georges, Joanne E. Greene, Michael Linenberger, Effie W. Petersdorf, Brenda M. Sandmaier, Bart L. Scott, Mohamed L. Sorror, Derek L. Stirewalt, F. Marc Stewart, Robert P. Witherspoon, Rainer Storb, Frederick R. Appelbaum, H. Joachim Deeg